Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Emergency funding for COVID-19 studies not requiring clinical trials

Date added:

Projects should carry out on rapid research into fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures.

Amount
Up to $275.000 (USD)
Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Higher education institutions, non-profit organisations, SMEs, for-profit organisations, governments

Foreign participation? (where known)
Yes

Advanced computing resources for research into COVID-19

Date added:

PRACE, the Partnership for Advanced Computing in Europe, wants to hear how its resources can contribute to the mitigation of the impact of the COVID-19 pandemic.

Amount
Resources vary
Agency or Funder
Partnership for Advanced Computing in Europe
Eligibility (if available)

Academia, Research institutes, Commercial organisations based in Europe

Foreign participation? (where known)
Yes

Special Call on Coronaviruses

Date added:

Any aspect of coronavirus research. Applicants may request up to 300,000 francs for projects lasting up to 24 months. Bigger grants are conceivable, provided the applicant has good reasons for requesting a higher amount.

Amount
CHF 5M
Agency or Funder
Swiss Nation Science Foundation
Foreign participation? (where known)
Yes
Date application deadline

Emergency call for COVID-19 research in the wake of the SARS-CoV-2 outbreak

Date added:

A rapid call to Austria businesses for COVID-19 projects lasting no longer than 12 months. To accelerate decision making, this call has a deadline of 8 April; a second call will have a deadline of 11 May.

Amount
€ 21 million
Agency or Funder
Österreichische Forschungsförderungsgesellschaft (FFG)
Eligibility (if available)

Austrian companies planning a research and development project in accordance with the KLIPHA-COVID19 tender guidelines

Foreign participation? (where known)
No
Date application deadline

BSAC COVID-19 Funding Call

Date added:

A COVID-19 funding call to support researchers in microbiology in better understanding and addressing COVID-19 outbreak.

Amount
up to £25,000
Agency or Funder
British Society for Antimicrobial Chemotherapy
Eligibility (if available)

Very broad, including early career researchers and clinical trainees. Note that applications are not normally encouraged from principal investigators and co-workers in receipt of grants in excess of £100K (or local equivalent) in the past two years. See stage.bsac.org.uk/funding/ for details.

Foreign participation? (where known)
Yes
Date application deadline

Emergency call for COVID-19 research in the wake of the SARS-CoV-2 outbreak

Date added:

A rapid call to Austria businesses for COVID-19 projects lasting no longer than 12 months. The second part of the rapid call (the first part has a deadline of 8 April).

Amount
€ 21 million
Agency or Funder
Österreichische Forschungsförderungsgesellschaft (FFG)
Eligibility (if available)

Austrian companies planning a research and development project in accordance with the KLIPHA-COVID19 tender guidelines

Foreign participation? (where known)
No
Date application deadline

Grants for organisations to work on COVID-19 healthcare education and best practice

Date added:

The funding will support healthcare providers focused on the recognition, diagnosis, treatment, and care management of patients with COVID-19.

Amount
$5,000,000 (U.S. dollars)
Agency or Funder
Pfizer
Eligibility (if available)

Medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations; government agencies; and other entities with a mission related to healthcare improvement. (Not individuals or medical practice groups.)

Foreign participation? (where known)
Yes
Date application deadline

Understanding the pathobiology and clinical implications of SARS-CoV-2

Date added:

Proposals may address the biology of respiratory viruses, epidemiological approaches to them, development of novel therapeutics and vaccines, deciding host factors and individual, regional, or social factors affecting community spread of COVID-19.

Amount
$100.000 (U.S. dollars) per year, for up to two years
Agency or Funder
American Lung Association
Eligibility (if available)

Applicants must hold a PhD and work in a non-profit academic institution

Date application deadline

Translate promising preclinical findings into products for clinical applications

Date added:

Projects should include emerging viral diseases and respiratory health topics – and be relevant to the healthcare needs of military service members, veterans, military beneficiaries, and/or the American public.

Amount
$25M (U.S. dollars)
Agency or Funder
U.S. Department of Defense (DoD)
Eligibility (if available)

Government agencies, eligible non-DoD organization, DoD laboratory, DoD military treatment facility, and/or DoD activity embedded within a civilian medical centre

Foreign participation? (where known)
No
Date application deadline

Basic research and COVID-19

Date added:

Projects must cover relate to medical and biological problems or economic and educational aspects of the pandemic.

Amount
BGN1.8M
Agency or Funder
Bulgarian National Science Fund
Eligibility (if available)

Scientific organisations and higher education institutions

Foreign participation? (where known)
No
Date application deadline

Call for funding to research COVID-19

Date added:

The biology of the virus and its transmission, animal and environmental research on the origin of the virus, including control measures at the human-animal interface, epidemiological studies, clinical characterization and clinical management, infe

Amount
€10M
Agency or Funder
Federal Ministry of Education and Research
Eligibility (if available)

Must comply with uniform standards for quality assurance of biomaterial banks, patient registers,
IT networking, animal studies, including ARRIVE guidelines

Foreign participation? (where known)
No
Date application deadline

Clinical trials for at-risk elderly people

Date added:

Project should focus on multi-site clinical trials to address ageing-related issues such as reducing transmission, risk, morbidity, mortality, severity, or complications of COVID-19.

Amount
Not limited
Agency or Funder
National Institutes of Health and National Institute on Aging
Eligibility (if available)

Higher education institutions, nonprofits, for-profit organisations, local and federal governments, non-U.S entities, non-U.S. components of U.S. organisations

Foreign participation? (where known)
Yes
Date application deadline

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

Date added:

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID & NIGMS
Eligibility (if available)

Existing grantholders wishing to expand the scope of their research.

Foreign participation? (where known)
Yes
Date application deadline

Rapid response call for UK-led research into COVID-19

Date added:

UKRI calls for projects with potential to deliver a significant contribution to the understanding, prevention or management of the COVID-19 outbreak within 12 months.

Amount
UK - 80% of full economic costs. Overseas - 100% direct costs only
Agency or Funder
UK Research and Innovation and the Department of Health and Social Care
Eligibility (if available)

Principal investigator must be hosted by an institution eligible for UKRI funding.

Foreign participation? (where known)
Yes
Date application deadline